Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q1

9627.TEDINET S100P6MT
Period2022-05-01 → 2022-07-31
Filed2022-09-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥81.5bn2022-05-01 → 2022-07-31Cons.Net sales
Revenue¥316.2bn2021-05-01 → 2022-04-30Cons.Net sales (5-year summary)
Revenue¥75.0bn2021-05-01 → 2021-07-31Cons.Net sales
Operating income¥2.8bn2022-05-01 → 2022-07-31Cons.Operating income
Operating income¥2.6bn2021-05-01 → 2021-07-31Cons.Operating income
Ordinary income¥3.1bn2022-05-01 → 2022-07-31Cons.Ordinary income
Ordinary income¥16.0bn2021-05-01 → 2022-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.9bn2021-05-01 → 2021-07-31Cons.Ordinary income
Profit before tax¥3.0bn2022-05-01 → 2022-07-31Cons.Income before income taxes
Profit before tax¥2.7bn2021-05-01 → 2021-07-31Cons.Income before income taxes
Net income (owners)¥1.7bn2022-05-01 → 2022-07-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥7.1bn2021-05-01 → 2022-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.3bn2021-05-01 → 2021-07-31Cons.Profit loss attributable to owners of parent
Net income¥1.7bn2022-05-01 → 2022-07-31Cons.Profit loss
Net income¥1.3bn2021-05-01 → 2021-07-31Cons.Profit loss
Total assets¥228.4bnat 2022-07-31Cons.Assets
Total assets¥212.5bnat 2022-04-30Cons.Assets
Total assets¥203.6bnat 2021-07-31Cons.Total assets (5-year summary)
Total liabilities¥109.6bnat 2022-07-31Cons.Liabilities
Total liabilities¥93.5bnat 2022-04-30Cons.Liabilities
Net assets / equity¥118.8bnat 2022-07-31Cons.Net assets
Net assets / equity¥119.0bnat 2022-04-30Cons.Net assets
Net assets / equity¥113.8bnat 2021-07-31Cons.Net assets (5-year summary)
Cash and deposits¥46.9bnat 2022-07-31Cons.Cash and deposits
Cash and deposits¥59.7bnat 2022-04-30Cons.Cash and deposits
EPS (basic)¥48.532022-05-01 → 2022-07-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥201.472021-05-01 → 2022-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥37.12021-05-01 → 2021-07-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio52.0%at 2022-07-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.0%at 2022-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio55.9%at 2021-07-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2022-05-01 → 2022-07-31¥2.9bn
Otherother segmentsrevenue external2022-05-01 → 2022-07-31¥2.9bn
Otherother segmentsrevenue intersegment2022-05-01 → 2022-07-31¥18m
Otherother segmentssegment ordinary income2022-05-01 → 2022-07-31¥4m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2022-07-31−¥18m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2022-07-31−¥18m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2022-07-31−¥1.8bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2022-07-31¥72.5bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2022-07-31¥72.5bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2022-07-31¥4.7bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2022-07-31¥6.1bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2022-07-31¥6.1bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2022-07-31¥164m
—segment totalrevenue2022-05-01 → 2022-07-31¥81.5bn
—segment totalrevenue external2022-05-01 → 2022-07-31¥81.5bn
—segment totalrevenue intersegment2022-05-01 → 2022-07-31¥18m
—segment totalsegment ordinary income2022-05-01 → 2022-07-31¥4.9bn
Otherother segmentsrevenue2021-05-01 → 2021-07-31¥3.1bn
Otherother segmentsrevenue external2021-05-01 → 2021-07-31¥3.1bn
Otherother segmentsrevenue intersegment2021-05-01 → 2021-07-31¥23m
Otherother segmentssegment ordinary income2021-05-01 → 2021-07-31¥13m
Reconciling Itemsreconcilingrevenue2021-05-01 → 2021-07-31−¥23m
Reconciling Itemsreconcilingrevenue intersegment2021-05-01 → 2021-07-31−¥23m
Reconciling Itemsreconcilingsegment ordinary income2021-05-01 → 2021-07-31−¥1.5bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentrevenue2021-05-01 → 2021-07-31¥66.8bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2021-05-01 → 2021-07-31¥66.8bn
jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2021-05-01 → 2021-07-31¥4.9bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2021-05-01 → 2021-07-31¥5.1bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2021-05-01 → 2021-07-31¥5.1bn
jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2021-05-01 → 2021-07-31−¥503m
—segment totalrevenue2021-05-01 → 2021-07-31¥75.0bn
—segment totalrevenue external2021-05-01 → 2021-07-31¥75.0bn
—segment totalrevenue intersegment2021-05-01 → 2021-07-31¥23m
—segment totalsegment ordinary income2021-05-01 → 2021-07-31¥4.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 372
ItemContextValueUnit
Loss on cancellation of leasehold contracts elPrior1YTDDuration118000000JPY
Loss on cancellation of leasehold contracts elCurrentYTDDuration－JPY
Other elPrior1YTDDuration31000000JPY
Other elCurrentYTDDuration11000000JPY
Extraordinary lossPrior1YTDDuration186000000JPY
Extraordinary lossCurrentYTDDuration98000000JPY
Income before income taxesPrior1YTDDuration2704000000JPY
Income before income taxesCurrentYTDDuration2996000000JPY
Income taxesPrior1YTDDuration1400000000JPY
Income taxesCurrentYTDDuration1292000000JPY
Profit lossPrior1YTDDuration1304000000JPY
Profit lossCurrentYTDDuration1703000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-4000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-0JPY
Profit loss attributable to owners of parentPrior1YTDDuration1309000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1704000000JPY
Profit lossPrior1YTDDuration1304000000JPY
Profit lossCurrentYTDDuration1703000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-40000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-14000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration10000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration6000000JPY
Other comprehensive incomePrior1YTDDuration-30000000JPY
Other comprehensive incomeCurrentYTDDuration-8000000JPY
Comprehensive incomePrior1YTDDuration1274000000JPY
Comprehensive incomeCurrentYTDDuration1695000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1279000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration1695000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-4000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-0JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E04896-000DispensingPharmacyReportableSegmentsMember66828000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember5063000000JPY
Revenues from external customersPrior1YTDDuration_OtherReportableSegmentsMember3119000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember75011000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration75011000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E04896-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_OtherReportableSegmentsMember23000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember23000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-23000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E04896-000DispensingPharmacyReportableSegmentsMember66828000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember5063000000JPY
Net salesPrior1YTDDuration_OtherReportableSegmentsMember3143000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember75034000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-23000000JPY
Net salesPrior1YTDDuration75011000000JPY
Ordinary incomePrior1YTDDuration_jpcrp040300-q1r_E04896-000DispensingPharmacyReportableSegmentsMember4879000000JPY
Ordinary incomePrior1YTDDuration_jpcrp040300-q1r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember-503000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-04-30pass rounding
balance sheet identityconsolidated 2022-07-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-04-30pass
statement vs summary · net assetsconsolidated 2022-07-31pass
statement vs summary · net income attributable to parentconsolidated 2021-05-01/2021-07-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2022-07-31pass
statement vs summary · revenueconsolidated 2021-05-01/2021-07-31pass
statement vs summary · revenueconsolidated 2022-05-01/2022-07-31pass
statement vs summary · total assetsconsolidated 2022-04-30pass
statement vs summary · total assetsconsolidated 2022-07-31pass